BRCA1/2 and homologous recombination repair alterations in high- and low-volume metastatic hormone-sensitive prostate cancer: prevalence and impact on outcomes
D. Olmos, D. Lorente, A. Jambrina, Daniel Velasco, María Ovejero-Sánchez, I. González Ginel, Nuria Romero-Laorden, Diogo Nunes‐Carneiro, M. Balongo, Ana Gutiérrez-Pecharromán, Casilda Llácer, Juan Daniel Prieto Cuadra, Daniel Pérez-Argüelles, F. Alberca Del Arco, J Miguel-Masiá, María Dolores Martínez Ruiz, Rui Santos, Jorge Esteban-Villarrubia, Enrique González‐Billalabeitia, A Jürgens, C. Capone, Marco Trevisan, Suzy Van Sanden, Thomas M. Stulnig, Domingo Hernández, Pedro P. López‐Casas, A. Rodrı́guez-Antolı́n, Daniel Castellano, Bernardo Herrera‐Imbroda, E. Castro
Topics & Concepts
MedicineProstate cancerHomologous recombinationOncologyProstateHormoneVolume (thermodynamics)Internal medicineRecombinationCancerCancer researchGeneticsGeneBiologyPhysicsQuantum mechanicsProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentPARP inhibition in cancer therapy